Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy

Cancer

Volumn 89, Issue 6, 2000, Pages 1308-1314

  Carvalhal, Gustavo F ^a,b,c   Humphrey, Peter A ^a   Thorson, Phataraporn ^a,d   Yan, Yan ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Hospital del Trabajador ACHS ^*  (Brazil)

^c HOSPITAL DEL TRABAJADOR   (Chile)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Carcinoma; Prognosis; Prostate; Prostate specific antigen; Prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; PROSTATE CARCINOMA; PROSTATECTOMY; RECURRENCE RISK;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 0034666415     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000915)89:6<1308::AID-CNCR16>3.0.CO;2-3     Document Type: Article

References (31)

1. Pathological factors that influence prognosis in Stage A prostatic cancer: The influence of extent versus grade
2. Morphometric and clinical studies on 68 consecutive radical prostatectomies
3. Morphometric measurement of tumor volume and percent of gland involvement as predictors of pathological stage in clinical Stage B prostate cancer
4. Intraglandular tumor extent and prognosis in prostatic carcinoma: Application of a grid method to prostatectomy specimens
5. Histologic grade, DNA ploidy, and intraglandular tumor extent as indicators of tumor progression of clinical Stage B prostatic carcinoma
6. Cancer volume and site of origin of adenocarcinoma in prostate: Relationship to local and distant spread
7. Staging of early prostate cancer: A proposed tumor volume-based prognostic index
8. Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate-specific antigen levels
9. Biological determinants of cancer progression in men with prostate cancer
10. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: The influence of prostate specific antigen cancer density
11. Tumor volume and prostate specific antigen: Implications for early detection and defining a window of curability
12. Percentage of free serum prostate-specific antigen as a predictor of pathologic features of prostate cancer in a screening population
13. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens
14. Localized prostate cancer: Relationship of tumor volume to clinical significance for treatment of prostate cancer
15. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
16. Radical prostatectomy for impalpable prostate cancer: The Johns Hopkins experience with tumors found on transurethral resection (Stages Tla and Tlb) and on needle biopsy (Stage Tlc)
17. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. Cancer Committee, College of American Pathologists
18. Recommendations for the reporting of resected prostate carcinomas
19. Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: Influence of tumor deoxyribonucleic acid ploidy
20. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical Stage B adenocarcinomas of the prostate with 5 years of follow up
21. Current prognostic factors and their relevance to staging Workgroup 3. International consultation on prostatic intraepithelial neoplasia and pathologic staging for prostatic carcinoma
22. Prognostic factors and clinical significance of cancers detected by screening: Growth rate and progression of prostate cancer
23. Morphology of prostate cancer: The effects of multifocality on histological grade, tumor volume and capsule penetration
24. Pathologic staging of prostate carcinoma: What are the issues? International consultation on prostatic intraepithelial neoplasia and pathologic staging of prostatic carcinoma
25. Nerve-sparing radical retropubic prostatectomy
26. The greatest dimension of prostate carcinoma is a simple, inexpensive predictor of prostate specific antigen failure in radical prostatectomy specimens
27. Radical prostatectomy
28. Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues
29. Surgical pathology examination of the prostate gland. Practice survey by the American Society of Clinical Pathologists